Kociszewski C, Thomas S H, Harrison T, Wedel S K
Boston Medflight Critical Care Transport Service, MA, USA.
Am J Emerg Med. 2000 Nov;18(7):757-63. doi: 10.1053/ajem.2000.18033.
The objective was to compare rates of successful endotracheal intubation (ETI) and requirement for multiple ETI attempts in patients receiving etomidate (ETOM) versus succinylcholine (SUX). This retrospective study analyzed adults in whom oral ETI was attempted by a helicopter EMS (HEMS) service between July 1997 to July 1999. Data were from records of the HEMS service, which uses a RN/EMTP crew; analysis was with chi-square and logistic regression (P = .05). ETI was successful in 269 (97.8%) of 275 patients, with multiple attempts occurring in 54 (20.1%) of 269. Success rates for SUX (209 of 213, 98.1%) and ETOM (60 of 62, 96.8%) were similar (P = .62). However, of 60 ETOM patients successfully intubated, 7 (11.7%) required rescue succinylcholine. When these patients are tallied as ETOM failures and SUX successes, resultant success rates for ETOM (86.9%) and SUX (98.2%) are different (P = .001). ETOM patients were more likely (P = .004) than SUX patients to require multiple attempts (33.3% versus 16.3%). ETI success rates were high in patients receiving SUX or ETOM as primary adjuncts for airway control, but initial success was more likely with SUX, and ETOM patients were more likely to require multiple attempts.
目的是比较接受依托咪酯(ETOM)与琥珀酰胆碱(SUX)的患者气管插管成功的比例以及多次气管插管尝试的需求情况。这项回顾性研究分析了1997年7月至1999年7月间由直升机紧急医疗服务(HEMS)进行经口气管插管尝试的成年患者。数据来自HEMS服务记录,该服务配备注册护士/急救医疗技术员团队;采用卡方检验和逻辑回归分析(P = 0.05)。275例患者中有269例(97.8%)气管插管成功,269例中有54例(20.1%)进行了多次尝试。SUX组(213例中的209例,98.1%)和ETOM组(62例中的60例,96.8%)的成功率相似(P = 0.62)。然而,在60例成功插管的ETOM患者中,有7例(11.7%)需要追加琥珀酰胆碱。若将这些患者计为ETOM插管失败而SUX插管成功,则ETOM组(86.9%)和SUX组(98.2%)的最终成功率不同(P = 0.001)。ETOM组患者比SUX组患者更有可能(P = 0.004)需要多次尝试(33.3%对16.3%)。作为气道控制主要辅助药物,接受SUX或ETOM的患者气管插管成功率较高,但SUX组首次插管更易成功,且ETOM组患者更有可能需要多次尝试。